David Arthur
Chief Executive Officer chez SALARIUS PHARMACEUTICALS, INC.
Fortune : 25 992 $ au 31/03/2024
Profil
David J.
Arthur is currently the President, Chief Executive Officer & Director at Salarius Pharmaceuticals LLC since 2015.
He is also currently the Chief Executive Officer & Director at Salarius Pharmaceuticals, Inc. since 2019.
Previously, he worked as the Managing Director at Dacon Pharma LLC from 2012 to 2015.
Mr. Arthur completed his undergraduate degree at North Carolina State University and holds an MBA from The Fuqua School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/04/2024 | 49 135 ( 1,14% ) | 25 992 $ | 31/03/2024 |
Postes actifs de David Arthur
| Sociétés | Poste | Début |
|---|---|---|
| SALARIUS PHARMACEUTICALS, INC. | Chief Executive Officer | 19/07/2019 |
Salarius Pharmaceuticals LLC
 Salarius Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Salarius Pharmaceuticals LLC manufactures drugs for cancer. It specializes in epigenetics, pipeline and LSD1 research, and development services. The company was founded by Jonathan P. Northrup and Sharma Sunil in 2014 and is headquartered in Houston, TX. | Chief Executive Officer | 01/11/2015 |
Anciens postes connus de David Arthur
| Sociétés | Poste | Fin |
|---|---|---|
| Dacon Pharma LLC | Corporate Officer/Principal | 01/10/2015 |
Formation de David Arthur
| North Carolina State University | Undergraduate Degree |
| The Fuqua School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SALARIUS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Salarius Pharmaceuticals LLC
Salarius Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Salarius Pharmaceuticals LLC manufactures drugs for cancer. It specializes in epigenetics, pipeline and LSD1 research, and development services. The company was founded by Jonathan P. Northrup and Sharma Sunil in 2014 and is headquartered in Houston, TX. | Health Technology |
| Dacon Pharma LLC |
